Hostname: page-component-5db58dd55d-m58mf Total loading time: 0 Render date: 2026-06-06T01:21:46.800Z Has data issue: false hasContentIssue false

The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides

Published online by Cambridge University Press:  09 March 2007

Ilja C. W. Arts*
Affiliation:
RIKILT– Institute of Food Safety, Wageningen University and Research Centre, Wageningen, The Netherlands
Aloys L. A. Sesink
Affiliation:
Department. of Pharmacology and Toxicology, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
Maria Faassen-Peters
Affiliation:
Small Animal Research Centre, Wageningen University, Wageningen, The Netherlands
Peter C. H. Hollman
Affiliation:
RIKILT– Institute of Food Safety, Wageningen University and Research Centre, Wageningen, The Netherlands
*
*Corresponding author: Dr Ilja C. W. Arts, fax +31 317 417717, email ilja.arts@wur.nl
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Quercetin is an important dietary flavonoid with putative beneficial effects in the prevention of cancer and CVD. The in vivo bioactivity of quercetin depends on its bioavailability, which varies widely between foods. We used an in situ rat intestinal perfusion model to study whether differential small intestinal hydrolysis of the sugar moiety of five naturally occurring quercetin glycosides determines the small intestinal uptake and subsequent biliary excretion of quercetin. After 30 min perfusion, a decrease of intact quercetin glycoside in perfusate was observed for quercetin-3-O-ß-glucoside (20·9 (sem 1·4) μmol/l) and quercetin-4′-O-ß-glucoside (23·5 (sem 1·6) μmol/l), but not of quercetin-3-O-ß-galactoside, quercetin-3-O-ß-rhamnoside and quercetin-3-O-α-arabinopyranoside. Appearance of free quercetin in perfusate and conjugated quercetin metabolites (quercetin, isorhamnetin, and tamarixetin) in portal and peripheral plasma and bile were also significantly greater after treatment with quercetin-3-O-ß-glucoside or quercetin-4′-O-ß-glucoside compared with any of the other glycosides. Thus, the type of sugar moiety is a major determinant of the small intestinal absorption of quercetin glycosides, but the position (3 or 4′) of the glucose moiety does not further influence absorption. The poor bioavailability of important dietary quercetin glycosides has implications for their in vivo bioactivities.

Information

Type
Research Article
Copyright
Copyright © The Nutrition Society 2004